CompareMarketResearchRequest a sample
Home / Healthcare / Immunohistochemistry

Healthcare · Market report

Immunohistochemistry Market Size, Share and Forecast 2026-2036

The global immunohistochemistry market is worth USD 3.5 bn in 2026 and is forecast to reach USD 7.5 bn by 2036, growing at a 8.0% CAGR. United States is the largest country market and Antibodies is the largest by product segment.

USD 3.5 bnMarket size 2026
USD 7.5 bnForecast 2036
8.0%CAGR 2026-2036
United StatesLargest country

Request a free sample Jump to the forecast

Report price: Starts from USD 1,999

5 segmentation views25 countries2026 to 2036 yearly forecast

Market overview

The global immunohistochemistry market is worth USD 3.5 bn in 2026 and is forecast to reach USD 7.5 bn by 2036, growing at a 8.0% CAGR. United States is the largest country market and Antibodies is the largest by product segment.

ScopeAntibodies, reagents, detection kits, automated staining instruments and consumables used in immunohistochemistry testing of tissue samples in pathology and research laboratories.
IndustryHealthcare
Value 2025USD 3.2 bn
Value 2026USD 3.5 bn
Value 2036USD 7.5 bn
CAGR 2026-20368.0%
Volume 2026214 million tests
Volume 2036418 million tests
Average price 2026USD 16.2 per test
Report priceStarts from USD 1,999
PublishedNovember 2026

Request a free sample of this report

Immunohistochemistry market size and forecast, 2026-2036

Exhibit 1The global immunohistochemistry market is forecast to grow from USD 3.5 bn in 2026 to USD 7.5 bn by 2036, more than doublingGlobal market value in USD: 2025 base year, 2026 estimate and forecast to 2036. CAGR 2026 to 2036: 8.0%
Immunohistochemistry market value, 2025 to 2036Market value by year. 2025: USD 3.2 bn; 2026: USD 3.5 bn; 2027: USD 3.7 bn; 2028: USD 4.0 bn; 2029: USD 4.4 bn; 2030: USD 4.7 bn; 2031: USD 5.1 bn; 2032: USD 5.5 bn; 2033: USD 5.9 bn; 2034: USD 6.4 bn; 2035: USD 6.9 bn; 2036: USD 7.5 bn. Compound annual growth rate 2026 to 2036: 8.0%.20253.5 bn20265.1 bn20317.5 bn20368.0% CAGR

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

YearMarket value
2026USD 3.5 bn
2027USD 3.7 bn
2028USD 4.0 bn
2029USD 4.4 bn
2030USD 4.7 bn
2031USD 5.1 bn
2032USD 5.5 bn
2033USD 5.9 bn
2034USD 6.4 bn
2035USD 6.9 bn
2036USD 7.5 bn

Immunohistochemistry market segmentation

By product

Exhibit 2Antibodies is the largest segment by product, with 38.0% of 2026 revenueEstimated share of 2026 global revenue, by product
Immunohistochemistry market share by product, 2026Share of 2026 revenue by product. Antibodies: 38.0%; Reagents and kits: 32.0%; Instruments and automated stainers: 22.0%; Software and consumables: 8.0%.Antibodies38.0%Reagents and kits32.0%Instruments and automated stainers22.0%Software and consumables8.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Antibodies38.0%36.1%USD 1.3 bn7.4%
Reagents and kits32.0%33.3%USD 1.1 bn8.4%
Instruments and automated stainers22.0%21.9%USD 760 mn7.9%
Software and consumables8.0%8.7%USD 276 mn8.9%

By application

Exhibit 3Cancer diagnostics adds the most revenue by application, growing from USD 2.4 bn in 2026 to USD 5.4 bn by 2036Estimated revenue in USD by application, 2026 and 2036 forecast
Immunohistochemistry market by application, 2026 and 2036Revenue by application in 2026 and 2036. Cancer diagnostics: USD 2.4 bn in 2026, USD 5.4 bn in 2036, change +124%; Drug discovery and research: USD 518 mn in 2026, USD 1.1 bn in 2036, change +104%; Infectious and autoimmune disease: USD 346 mn in 2026, USD 674 mn in 2036, change +95%; Other: USD 173 mn in 2026, USD 307 mn in 2036, change +78%.20262036 forecastChangeCancer diagnostics+124%2.4 bn5.4 bnDrug discovery and research+104%518 mn1.1 bnInfectious and autoimmune disease+95%346 mn674 mnOther+78%173 mn307 mn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Cancer diagnostics70.0%72.7%USD 2.4 bn8.4%
Infectious and autoimmune disease10.0%9.0%USD 346 mn6.9%
Drug discovery and research15.0%14.2%USD 518 mn7.4%
Other5.0%4.1%USD 173 mn5.9%

By end user

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Hospitals and diagnostic laboratories58.0%58.9%USD 2.0 bn8.2%
Pharma and biotech22.0%23.4%USD 760 mn8.7%
Academic and research institutes20.0%17.7%USD 691 mn6.7%

By detection

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Chromogenic54.0%48.0%USD 1.9 bn6.7%
Fluorescent24.0%26.0%USD 829 mn8.9%
Multiplex22.0%26.0%USD 760 mn9.8%

By sample type

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Formalin-fixed paraffin-embedded tissue68.0%62.0%USD 2.4 bn7.0%
Frozen tissue16.0%16.0%USD 553 mn8.0%
Cytology and cell preparations16.0%22.0%USD 553 mn11.5%

Top 25 countries for immunohistochemistry by revenue

Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 85.5% of 2026 revenue and the 25 countries below together hold 95.9%.

Exhibit 4United States is the largest country market at USD 1.3 bn in 2026, and the three largest countries hold 59.0% of global revenueEstimated 2026 revenue in USD and share of the global market, ten largest countries
Immunohistochemistry market, ten largest countries in 2026Ten largest countries by 2026 revenue. United States: USD 1.3 bn, 38.0%; China: USD 484 mn, 14.0%; Germany: USD 242 mn, 7.0%; Japan: USD 207 mn, 6.0%; United Kingdom: USD 173 mn, 5.0%; France: USD 138 mn, 4.0%; Italy: USD 104 mn, 3.0%; India: USD 104 mn, 3.0%; Canada: USD 104 mn, 3.0%; South Korea: USD 86 mn, 2.5%.United States1.3 bn 38.0%China484 mn 14.0%Germany242 mn 7.0%Japan207 mn 6.0%United Kingdom173 mn 5.0%France138 mn 4.0%Italy104 mn 3.0%India104 mn 3.0%Canada104 mn 3.0%South Korea86 mn 2.5%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

#CountryValue 2026Share 2026Value 2036CAGR 2026-36
1United StatesUSD 1.3 bn38.0%USD 2.7 bn7.4%
2ChinaUSD 484 mn14.0%USD 1.4 bn10.9%
3GermanyUSD 242 mn7.0%USD 448 mn6.3%
4JapanUSD 207 mn6.0%USD 366 mn5.8%
5United KingdomUSD 173 mn5.0%USD 336 mn6.9%
6FranceUSD 138 mn4.0%USD 261 mn6.6%
7ItalyUSD 104 mn3.0%USD 194 mn6.5%
8IndiaUSD 104 mn3.0%USD 321 mn12.0%
9CanadaUSD 104 mn3.0%USD 209 mn7.3%
10South KoreaUSD 86 mn2.5%USD 194 mn8.4%
11SpainUSD 38 mn1.1%USD 76 mn7.3%
12AustraliaUSD 38 mn1.1%USD 76 mn7.3%
13BrazilUSD 32 mn0.9%USD 81 mn9.7%
14NetherlandsUSD 27 mn0.8%USD 54 mn7.3%
15SwitzerlandUSD 27 mn0.8%USD 54 mn7.3%
16MexicoUSD 21 mn0.6%USD 54 mn9.8%
17TaiwanUSD 21 mn0.6%USD 43 mn7.3%
18RussiaUSD 21 mn0.6%USD 43 mn7.3%
19TurkeyUSD 21 mn0.6%USD 54 mn9.8%
20BelgiumUSD 21 mn0.6%USD 43 mn7.3%
21SwedenUSD 21 mn0.6%USD 43 mn7.3%
22SingaporeUSD 21 mn0.6%USD 54 mn9.8%
23PolandUSD 16 mn0.5%USD 33 mn7.3%
24DenmarkUSD 16 mn0.5%USD 33 mn7.3%
25Saudi ArabiaUSD 16 mn0.5%USD 41 mn9.7%
Rest of worldUSD 141 mn4.1%USD 296 mn7.7%
Exhibit 5United States and China account for 56% of the USD 4.0 bn the market is forecast to add by 2036Forecast revenue added between 2026 and 2036 by country, in USD
Immunohistochemistry market, where the growth to 2036 comes fromRevenue added between 2026 and 2036. Market value 2026: USD 3.5 bn. United States: +USD 1.4 bn; China: +USD 882 mn; India: +USD 217 mn; Germany: +USD 206 mn; United Kingdom: +USD 163 mn; 20 other countries: +USD 1.0 bn; Rest of world: +USD 155 mn. Market value 2036: USD 7.5 bn.Market value 20263.5 bnUnited States+1.4 bnChina+882 mnIndia+217 mnGermany+206 mnUnited Kingdom+163 mn20 other countries+1.0 bnRest of world+155 mnMarket value 20367.5 bn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

Competitive landscape

Group 1: Global leaders

  • Roche
  • Agilent Technologies
  • Leica Biosystems
  • Thermo Fisher Scientific
  • Merck KGaA

Group 2: Regional and specialist players

  • Abcam
  • Cell Signaling Technology
  • Bio-Techne
  • Sakura Finetek
  • Epredia
  • Cell Marque
  • Maixin Biotech
  • ZSGB-BIO
  • Zytomed Systems

Group 3: Emerging and niche players

  • Biocare Medical
  • BioGenex
  • Diagnostic BioSystems
  • Histo-Line Laboratories
  • Akoya Biosciences
  • Vector Laboratories

Research methodology

Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the immunohistochemistry market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.

The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 8.0% is calculated from the resulting values.

The market is divided by product, by application, by end user, by detection, by sample type. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.

Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.

Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.

Read the full research methodology

Frequently asked questions

How big is the immunohistochemistry market?

The global immunohistochemistry market is estimated at USD 3.2 bn in 2025 and USD 3.5 bn in 2026.

How fast will the immunohistochemistry market grow?

It is forecast to reach USD 7.5 bn by 2036, a compound annual growth rate of 8.0% from 2026, an increase of USD 4.0 bn.

Which country is the largest market for immunohistochemistry?

United States is the largest market by revenue at USD 1.3 bn in 2026, 38.0% of the global total. The three largest countries together hold 59.0%.

Which country is growing fastest?

Among the ten largest markets, India is growing fastest at 12.0% a year from 2026 to 2036.

Which immunohistochemistry segment is largest?

In the by product split, Antibodies is the largest segment with 38.0% of 2026 revenue.

Who are the leading immunohistochemistry companies?

Global leaders include Roche, Agilent Technologies, Leica Biosystems, Thermo Fisher Scientific.

Need the full report?

Request a sample to see the structure, tables and country detail.

Request a free sample

Related markets in Healthcare

← Immunoassay Immunotherapy →

All Healthcare markets →

Request a sample